BRIEF

on DBV TECHNOLOGIES (EPA:DBV)

Half-yearly review of the DBV Technologies liquidity contract with ODDO BHF

DBV Technologies, a French biopharmaceutical laboratory, has published the half-yearly report of its liquidity contract with ODDO BHF. As of June 30, 2024, the liquidity account included 303,744 DBV Technologies securities and 62,415.60 euros.

When the contract was set up, on July 1, 2018, the account included 41,159 securities and 432,367.25 euros. Between January 1, 2024 and June 30, 2024, 912 purchase transactions and 694 sale transactions were executed.

The volumes traded during this period were 299,986 securities and 397,966 euros for purchase, and 219,230 securities and 310,114 euros for sale. These figures demonstrate sustained activity over the first half of 2024.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DBV TECHNOLOGIES news